Procyon Corporation (PCYN)
OTCMKTS
· Delayed Price · Currency is USD
0.1800
0.00 (0.00%)
At close: Feb 3, 2025
Procyon Revenue
In the fiscal year ending June 30, 2024, Procyon had annual revenue of $4.98M with 6.35% growth. Procyon had revenue of $1.41M in the quarter ending June 30, 2024, with 17.51% growth.
Revenue
4.98M
Revenue Growth
+6.35%
P/S Ratio
0.29
Revenue / Employee
249.22K
Employees
20
Market Cap
1.47M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 4.98M | 297.77K | 6.35% |
| Jun 30, 2023 | 4.69M | -155.77K | -3.22% |
| Jun 30, 2022 | 4.84M | 122.76K | 2.60% |
| Jun 30, 2021 | 4.72M | 385.58K | 8.90% |
| Jun 30, 2020 | 4.33M | 142.90K | 3.41% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SS Innovations International | 20.65M |
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Northwest Biotherapeutics | 1.38M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 200.90M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
Procyon News
- 5 weeks ago - Deals & Moves: Clearstead Names Board Head, Procyon Adds Investment Expertise - Wealth Management
- 2 months ago - Starwatch: How to find the often overlooked constellation Monoceros - The Guardian
- 3 months ago - UBS Loses Advisors to Procyon Partners, Raymond James - Wealth Management
- 5 months ago - $7B RIA Procyon Hires Advisor Recruiter From Baird - Wealth Management